This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignees: Acceleron Pharma Inc., Celgene Corporation. Active years: 2022.
Company Filing History:
1 out of 172 
1 out of 561 
Years Active: 2022
Title: Abderrahmane Laadem: Innovator in Anemia Treatment
Introduction
Abderrahmane Laadem is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of anemia. His innovative approach has led to the development of a patent that addresses critical health issues.
Latest Patents
Laadem holds a patent for "Activin-ActRII antagonists and uses for treating anemia." This patent outlines methods for treating anemia, including conditions that require red blood cell transfusions, low or intermediate-1-risk myelodysplastic syndromes (MDS), and non-proliferative chronic myelomonocytic leukemia (CMML) in mammals. The methods involve the administration of Activin-ActRII signaling inhibitors to subjects in need of treatment.
Career Highlights
Throughout his career, Laadem has worked with prominent companies in the pharmaceutical industry. He has been associated with Celgene Corporation and Acceleron Pharma Inc., where he contributed to advancements in medical treatments.
Collaborations
Laadem has collaborated with esteemed colleagues, including Kenneth M Attie and Christopher Robert Rovaldi. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Abderrahmane Laadem's work in developing treatments for anemia showcases his dedication to improving patient outcomes. His innovative patent and collaborations with industry leaders highlight his significant impact on medical research and treatment methodologies.